Close

Industry Updates

Nomad Health keen on healthcare jobs nationwide, lifts up $12 Million for marketplace

Nomad Health, the first online marketplace for healthcare jobs, has raised $12 million in its Series B financing. Nomad Health will use the proceeds to fortify the technology that drives the marketplace, expand into more states on its way...

Express Scripts claims higher profits in fourth quarter

Pharmacy benefit manager Express Scripts Holding Co (ESRX.O) reported fourth-quarter profit on Tuesday above Wall Street estimates, benefiting from a rise in patient claims and strong customer retention. Shares of the company rose 3.6 percent at $81.44 after the bell. The...

Customer Service Department of the Year Winner is United Healthcare

UnitedHealthcare is a winner in the Customer Service Department of the Year category, presented by the Stevie Awards, an international awards program recognizing outstanding performances in the workplace. The results were announced Friday, Feb. 23, in Las Vegas, attended...

AMA yet to ask regulatory agencies to block the $69 billion acquisition of Aetna by drugstore giant CVS Health

Unlike its more aggressive stance against health insurance mergers, the American Medical Association has yet to ask Congress and regulatory agencies to block the $69 billion acquisition of Aetna by drugstore giant CVS Health. The AMA was perhaps the most...

CVS Health amongst 2018 World’s Most Innovative Companies List: Fast company

CVS Health , the nation's largest pharmacy innovation company, was recognized today by Fast Company as one of the World's 50 Most Innovative Companies List for 2018. CVS Health was also honored as No. 7 on Fast Company's Top...

Mckesson speciality health collaborates with Cryoport to enhance logistics services to shore up commercialization of cell and Gene therapies

McKesson Specialty Health, a division of McKesson Corporation, announced a strategic collaboration with Cryoport, Inc. designed to further strengthen its robust logistics services to support the delivery of cell and gene therapies to patients at the point of care. Adding...

New Late-Breaking XARELTO® (rivaroxaban) and INVOKANA® (canagliflozin) Data to be Presented at the American College of Cardiology’s Annual Scientific Session

New studies and late-breaking analyses from the Janssen Pharmaceutical Companies of Johnson & Johnson are among the 11 company abstracts accepted for presentation at the American College of Cardiology’s 67th Annual Scientific Session (ACC.18) taking place March 10-12, 2018,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read